Plain-English translation of NCT04415203 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcutaneous auricular vagus nerve stimulation (TAVNS)—a gentle, non-invasive treatment that uses electrical stimulation on specific points of the ear—to see if it can reduce frequent premature ventricular complexes, which are extra heartbeats that occur out of rhythm. The study will compare the real treatment to a sham (fake) version, with both groups also receiving their regular heart medications. The goal is to find out whether this ear-based treatment, combined with usual care, can significantly reduce these irregular heartbeats.
Frequent irregular heartbeats can be uncomfortable and sometimes worrying, but many people don't respond well to medications alone or experience side effects. This trial exists to explore whether stimulating a nerve in the ear—which connects to the heart—might offer a safe, additional treatment option that could help reduce these extra heartbeats when combined with standard care.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either real ear stimulation or sham (fake) stimulation, along with your usual heart medications. You will come in for treatment sessions over 6 weeks, then be followed up for an additional 12 weeks after that. The treatment involves placing a small device on specific points of your ear; the research team will monitor your heart rhythm using a 24-hour heart monitor to measure how many extra heartbeats you have before and after treatment, and they will also check your symptoms and overall wellbeing throughout the study.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China